| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/20/2004 | CA2396927C Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/15/2004 | WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same |
| 07/15/2004 | WO2004058770A1 Triptolide derivatives and their use |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058295A1 Remedy for pemphigoid |
| 07/15/2004 | WO2004058294A1 Uses of interleukin-18 for treating skin disorders associated with uv radiations |
| 07/15/2004 | WO2004058282A2 Method of obtaining a soothing active ingredient, active ingredient and compositions obtained |
| 07/15/2004 | WO2004058256A1 Pharmaceutical liquid composition containing pyridone derivative |
| 07/15/2004 | WO2004058178A2 Uses of mammalian cytokine; related reagents |
| 07/15/2004 | WO2004052353A3 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004034958A3 Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin |
| 07/15/2004 | WO2004032879A3 Compounds, compositions, and methods |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138203 Antiserotonine agents |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138103 Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137088 Improved, color-stable extract of St John's wort having reduced or absent amounts of chorophyll and proanthocyanidins; gels for skin disorders and mucous membrane irritations; acne, atopic dermatitis; neurodermatitis; bactericides; viricides |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137022 administration of effective amounts of manganese or salts to individuals suffering from skin color defficiency due to stress, positively affects the calcium channels to relax or slacken cutaneous vascular tissues and thus combats skin pallor |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136979 block, retard or reduce connective tissues regeneration; molecules released by catheters, surgical instruments or stents for angioplasty to prevent restenosis; atherosclerosis |
| 07/15/2004 | US20040136941 Cosmetic and dermatological preparation for removing sebum or regulating sebum production |
| 07/15/2004 | US20040136925 mixture of hyaluronic acids of various molecular weight, properly added with suitable diluents, which demonstrated to possess an interesting antiflogistic, antioxidant and tissue repair activity |
| 07/15/2004 | US20040135119 Liquid crystalline polymers mixture:, display, optics, diagnosis |
| 07/15/2004 | DE20320103U1 Composition for topical treatment of skin, useful for treating e.g. eczema and pruritus, comprises a fatty alcohol and three specific plant extracts |
| 07/15/2004 | DE10320604A1 Partikel umfassend ein Biopolymer, das unter Einwirkung von elektromagnetischen Wellen, ausgestrahlt durch Sonneneinstrahlung, abbaubar ist Particles comprising a biopolymer that is under the influence of electromagnetic waves emitted by the sun, degradable |
| 07/15/2004 | DE10312259A1 Kosmetische oder dermopharmazeutische Zusammensetzung, umfassend ein Enzym, das in einem wässrigen Medium unlöslich ist, sowie deren Verwendung Cosmetic or dermopharmaceutical composition comprising an enzyme, which is insoluble in an aqueous medium, and the use thereof |
| 07/15/2004 | CA2511612A1 Uses of interleukin-18 for treating skin disorders associated with uv radiations |
| 07/15/2004 | CA2511209A1 Agent for treatment of pemphigoid |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437121A1 Anti-dandruff composition for hair and scalp |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436334A1 Polymers with structure-defined functions |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436287A2 Small organic molecule regulators of cell proliferation |
| 07/14/2004 | EP1436281A1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436264A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 07/14/2004 | EP1436257A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1436012A2 Polymer conjugates of opioid antagonists |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1435999A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435972A2 Novel synthetic ganglioside derivatives and compositions thereof |
| 07/14/2004 | EP1435970A2 Methods of treating skin with diphosphonate derivatives |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435927A2 Method for treating skin disorders |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435917A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 07/14/2004 | EP1435906A2 Method for producing biologically active products |
| 07/14/2004 | EP1435899A1 A composition for promoting hair growth |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1435787A2 Nestin-expressing hair follicle stem cells |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1357926B1 Local use of ethereal oils |
| 07/14/2004 | EP1248630B1 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1117373B1 Hair tonic |
| 07/14/2004 | EP1079799B1 Use of an antimicrobial agent |
| 07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |